Tags

Type your tag names separated by a space and hit enter

Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY.
Clin Gastroenterol Hepatol. 2020 09; 18(10):2378-2379.e1.CG

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus responsible for coronavirus disease 2019 (COVID-19).1,2 The virus enters cells via the angiotensin-converting enzyme 2 receptor, which is present in enterocytes in the ileum and colon.3 Gastrointestinal (GI) manifestations include diarrhea, nausea, vomiting, and abdominal pain, and the prevalence of GI symptoms varies greatly, with a range between 2% and 57%.4 In addition, abnormal liver chemistries are reported commonly.4 As a medical center at the forefront of the early epidemic in the United States, we seek to contribute to the growing body of literature that outlines the gastrointestinal and hepatic manifestations of COVID-19.

Authors+Show Affiliations

Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York. Electronic address: Saf9081@nyp.org.Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York.Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York.Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York.Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York.Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York.Department of Population Health Sciences, Weill-Cornell Medicine, New York, New York.Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York.Division of Gastroenterology, New York-Presbyterian Queens Hospital, Flushing, New York.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

32497637

Citation

Ferm, Samson, et al. "Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY." Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, vol. 18, no. 10, 2020, pp. 2378-2379.e1.
Ferm S, Fisher C, Pakala T, et al. Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY. Clin Gastroenterol Hepatol. 2020;18(10):2378-2379.e1.
Ferm, S., Fisher, C., Pakala, T., Tong, M., Shah, D., Schwarzbaum, D., Cooley, V., Hussain, S., & Kim, S. H. (2020). Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 18(10), 2378-e1. https://doi.org/10.1016/j.cgh.2020.05.049
Ferm S, et al. Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY. Clin Gastroenterol Hepatol. 2020;18(10):2378-2379.e1. PubMed PMID: 32497637.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY. AU - Ferm,Samson, AU - Fisher,Constantine, AU - Pakala,Tina, AU - Tong,Michelle, AU - Shah,Disha, AU - Schwarzbaum,David, AU - Cooley,Victoria, AU - Hussain,Syed, AU - Kim,Sang Hoon, Y1 - 2020/06/01/ PY - 2020/05/18/received PY - 2020/05/26/revised PY - 2020/05/27/accepted PY - 2020/6/5/pubmed PY - 2020/9/4/medline PY - 2020/6/5/entrez SP - 2378 EP - 2379.e1 JF - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association JO - Clin Gastroenterol Hepatol VL - 18 IS - 10 N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus responsible for coronavirus disease 2019 (COVID-19).1,2 The virus enters cells via the angiotensin-converting enzyme 2 receptor, which is present in enterocytes in the ileum and colon.3 Gastrointestinal (GI) manifestations include diarrhea, nausea, vomiting, and abdominal pain, and the prevalence of GI symptoms varies greatly, with a range between 2% and 57%.4 In addition, abnormal liver chemistries are reported commonly.4 As a medical center at the forefront of the early epidemic in the United States, we seek to contribute to the growing body of literature that outlines the gastrointestinal and hepatic manifestations of COVID-19. SN - 1542-7714 UR - https://www.unboundmedicine.com/medline/citation/32497637/Analysis_of_Gastrointestinal_and_Hepatic_Manifestations_of_SARS_CoV_2_Infection_in_892_Patients_in_Queens_NY_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(20)30756-4 DB - PRIME DP - Unbound Medicine ER -